Decadentate Acyclic Chelators for Lanthanum Radiopharmaceuticals

UDC.coleccionInvestigación
UDC.departamentoQuímica
UDC.endPage17839
UDC.grupoInvReactividade Química e Fotorreactividade (REACT!)
UDC.institutoCentroCICA - Centro Interdisciplinar de Química e Bioloxía
UDC.issue16
UDC.journalTitleJournal of Medicinal Chemistry
UDC.startPage17823
UDC.volume68
dc.contributor.authorFreire-García, Antía
dc.contributor.authorArgibay-Otero, Saray
dc.contributor.authorRodríguez-Rodríguez, Aurora
dc.contributor.authorEsteban-Gómez, David
dc.contributor.authorPlatas-Iglesias, Carlos
dc.contributor.authorTircsó, Gyula
dc.contributor.authorWuest, Frank
dc.date.accessioned2026-05-18T12:19:01Z
dc.date.available2026-05-18T12:19:01Z
dc.date.issued2025-08-19
dc.description.abstract[Abstract]Two decadentate acyclic chelators bearing four picolinic acid groups appended on either an ethylenediamine (H4TPAEN) or a trans-1,2-cyclohexyldiamine (H4TPADAC) unit were explored as candidates for lanthanum-based radiopharmaceutical development. The two chelators form ten-coordinated complexes with La3+ in the solid state, as evidenced by the corresponding X-ray structures and solution NMR studies. The La3+ complexes of TPAEN4– and TPADAC4– are characterized by high thermodynamic stability constants of log KLaL = 19.16(8) and 19.55(1), respectively. Kinetics studies indicate that the complexes dissociate following the acid-catalyzed and Cu2+-assisted pathways. Quantitative radiolabeling of both chelators with [135La]La3+ was achieved at pH ∼ 4–5 using straightforward protocols and low concentrations of the chelator (3 μM). Both in vitro and in vivo studies indicate that the [135La]La3+ complex of TPAEN4– is significantly more stable than the TPADAC4– analogue, with the former remaining intact and stable even after 60 min in vivo when injected to healthy mice
dc.description.sponsorshipAuthors D.E.-G. and C.P.-I. thank Ministerio de Ciencia, Innovación y Universidades and FEDER (Grant PID2022-138335NB-I00) and Xunta de Galicia (ED431C 2023/33) for generous financial support. A.F.-G. thanks Ministerio de Universidades (Grant FPU21/06305) for funding her Ph.D contract. L.V. and S.A.-O. are indebted to CACTI (Universidade de Vigo) for X-ray measurements. Part of the artwork shown in the Table of Contents graphic was adapted from pictures provided by Servier Medical Art licensed under a Creative Commons Attribution 4.0 International License. The project was granted by the Hungarian National Research Development and Innovation Office (NKFIH K-134694 (Gy.T.)) and supported by Program for Scientific Publication of University of Debrecen. F.W. thanks the New Frontiers in Research Fund (grant NFRFT-2022-00269) and the Dianne and Irving Kipnes Foundation for supporting this work. Funding for open access was provided by Universidade da Coruna/CISUG
dc.description.sponsorshipXunta de Galicia; ED431C 2023/33
dc.description.sponsorshipHungría. The Hungarian National Research Development and Innovation Office; NFRFT-2022-00269
dc.description.sponsorshipFinanciado para publicación en acceso aberto: Universide da Coruña/CISUG
dc.identifier.citationJ. Med. Chem. 2025, 68, 16, 17823–17839 https://doi.org/10.1021/acs.jmedchem.5c01558
dc.identifier.doi10.1021/acs.jmedchem.5c01558
dc.identifier.issn0022-2623
dc.identifier.issn1520-4804
dc.identifier.urihttps://hdl.handle.net/2183/48294
dc.language.isoeng
dc.publisherACS
dc.relation.projectIDInfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2022-138335NB-I00/ES/ AGENTES QUELATANTES PARA UNA NUEVA GENERACION DE RADIOFARMACOS/
dc.relation.projectIDinfo:eu-repo/grantAgreement/MUNI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/FPU21%2F06305/ES/
dc.relation.urihttps://doi.org/10.1021/acs.jmedchem.5c01558
dc.rights© 2025 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY 4.0
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectDissociation
dc.subjectLigands
dc.subjectMechanisms of action
dc.subjectReaction mechanisms
dc.subjectStability
dc.titleDecadentate Acyclic Chelators for Lanthanum Radiopharmaceuticals
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication21e8beb3-8f00-4aa1-8533-9c8b1f85ac72
relation.isAuthorOfPublicationee348c15-3398-4e8a-ae54-5d3a9b713f0e
relation.isAuthorOfPublicationf30c18a2-108e-44d6-a7d2-b3b4e378509b
relation.isAuthorOfPublication8bb35ae5-5c53-4d41-87b8-949a82445202
relation.isAuthorOfPublication.latestForDiscovery21e8beb3-8f00-4aa1-8533-9c8b1f85ac72

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
FreireGarcia_Antia_2025_ Decadentate_Acyclic_Chelators_for_Lanthanum_Radiopharmaceuticals.pdf
Size:
4.46 MB
Format:
Adobe Portable Document Format